MCK Mckesson (MCK) Insider Trading, Ownership & Congress Trades
Wholesale & Retail · Wholesale-drugs, proprietaries & druggists' sundries · CIK 0000927653
Congress · 3Form 144 · 3
Insider buyers, 180 days
0
Funds added, last quarter
894
13F, latest reported quarter
Conversions, 180 days
20
Codes C/M, not in net · $0 priced
What the filings say about MCK
Insiders, 180 days
-$24.8M net sold
7 sellers · 17% of sales under a 10b5-1 plan
Congress, 1 year
3 bought · 3 sold
Latest: purchase, 2026-07-08
Planned sales (Form 144), 90 days
$7.7M
3 notices
Mckesson insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, MCKESSON CORP insiders sold a net $24.8M of stock across 187 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 14.8% of the 5,423 shares held after it.
- No other insider sold within 30 days.
- 894 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, CIO and CTO Fraga Francisco sold about $797.1K of MCK under a 10b5-1 plan on Oct 15, 2026; 894 funds added in the latest 13F quarter.Context
- 9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Jun 5, 2026.
- The trade is 21.3% of the 521 shares held after it.
- 1 other insider sold within 30 days.
- 894 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Controller & CAO Rutledge Napoleon B JR sold about $99.0K of MCK under a 10b5-1 plan on Sep 8, 2026; 1 other insider sold within 30 days and 894 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- 1 other insider sold within 30 days.
- 894 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Lerman Bradley E sold about $268.6K of MCK on Aug 10, 2026; 1 other insider sold within 30 days and 894 funds added in the latest 13F quarter.Context
- 66 earlier Form 4 trades (code P or S) here by this insider (66 sales), the last on Jun 17, 2026.
- The trade is 143.0% of the 5,919 shares held after it.
- No other insider sold within 30 days.
- 894 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer TYLER BRIAN S. sold about $6.7M of MCK on Jul 7, 2026; 894 funds added in the latest 13F quarter.Context
- 65 earlier Form 4 trades (code P or S) here by this insider (65 sales), the last on Jun 9, 2026.
- The trade is 58.8% of the 14,382 shares held after it.
- 4 other insiders sold within 30 days.
- 894 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer TYLER BRIAN S. sold about $6.6M of MCK on Jun 17, 2026; 4 other insiders sold within 30 days and 894 funds added in the latest 13F quarter.187 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$24.8M over 180 days
-$1.2M over 90 days
below 88% of Wholesale & Retail
Congress
3 members bought in the last year
more than 89% of Wholesale & Retail
Funds
894 funds bought in last quarter
more than 97% of Wholesale & Retail
Revenue
+12.4% year over year
more than 79% of Wholesale & Retail
Margin
1.2% net margin
more than 51% of Wholesale & Retail
Buybacks
$2.5B repurchased, FY to 2026-06-30
more than 99% of Wholesale & Retail
Short interest
2.0% of the float short (float per yahoo 2026-10-26) · 2.6 days to cover · settled 2026-09-30
below 58% of Wholesale & Retail
The situation: each line is one rule over one dataset
Federal contracts worth $1.4B were awarded in the last 180 days.
What changed in the last 30 days
Oct 19EVP, CIO and CTO Fraga Francisco sold $797.1K under a 10b5-1 plan (Oct 15)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 15Officer Fraga Francisco filed to sell $797.1K by Oct 15 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Watch MCK
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+26.1%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns MCK: institutional holders (13F)
13F holdings, latest reported quarter
10,795,054 sh
$8.2B
7,853,137 sh
$5.9B
5,727,118 sh
$4.3B
5,306,142 sh
$4.0B
2,905,114 sh
$2.2B
Congress trades in MCK
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Bought 2026-07-08 · disclosed 4 days later
$1,001 - $15,000
Sold 2026-06-15 · disclosed 30 days later
$1,001 - $15,000
Sold 2026-04-08 · disclosed 23 days later
$1,001 - $15,000
Sold 2025-12-19 · disclosed 24 days later
$1,001 - $15,000
Bought 2025-12-02 · disclosed 45 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
MCK planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Fraga Francisco
Filed 2026-10-15
$797.1K
Lerman Bradley E
Filed 2026-08-10
$268.6K
Vitalone Britt J.
Filed 2026-08-03
$6.7M
TYLER BRIAN S.
Filed 2026-07-07
$6.7M
MCK mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
SMI 3Fourteen Full-Cycle Trend ETF
$12.3M position · as of 2026-06-30
5.0%
Towpath Focus Fund
$3.6M position · as of 2026-05-31
4.9%
Saratoga Health & Biotechnology Fund
$513.0K position · as of 2026-05-31
4.9%
Select Health Care Services Portfolio
$38.9M position · as of 2026-05-31
4.8%
Muhlenkamp Fund
$12.4M position · as of 2026-06-30
4.7%
PIN OAK EQUITY FUND
$6.9M position · as of 2026-07-31
4.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Government contracts
Award ceilings over the contract's life, subsidiaries included.
Not annual revenue (USASpending.gov).
Department Of Veterans Affairs
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY · 2026-05-01
$1.4B
Department Of Health And Human Services
CENTRALIZED VACCINE DISTRIBUTION · 2024-02-01
$203.9M
Department Of Health And Human Services
MEDICARE PART D TRANSACTION FACILITATOR · 2021-08-01
$128.1M
Department Of Veterans Affairs
EDI P2E SERVICES · 2024-07-01
$51.3M
Department Of Justice
MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025. · 2025-10-01
$24.5M
Department Of Homeland Security
THE PURPOSE OF THIS CONTRACT IS TO PROVIDE ICE HEALTH SERVICE CORPS WITH PHARMACEUTICAL PRODUCTS. · 2026-01-30
$18.6M
Federal awards ≥ $25M in the last 90 days, matched via the SAM.gov parent registry
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Mckesson Corporation Employees Political Fund
Cycle 2026 · $754K spent
$696.0K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Brian S. Tyler
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$24.2M
$48.9M
$5.5M
+356%
+37%
2024
$20.2M
$39.2M
$5.0M
+253%
+34%
2023
$19.0M
$51.7M
$5.2M
+181%
+33%
2022
$20.2M
$38.8M
$4.9M
+85%
+15%
2021
$18.2M
$65.3M
$4.5M
+58%
+19%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $24.8M sold by insiders over 180 days, 894 funds added last quarter, 3 House member(s) bought in 12 months, disclosed weeks after the trade, $7.7M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
MCK financials
Revenue growth
+12.4%
XBRL, annual
Net margin
1.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$411.0B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM MCK
| FY Mar 2026 | $403.4B |
| FY Mar 2025 | $359.1B |
| FY Mar 2024 | $309.0B |
| FY Mar 2023 | $276.7B |
| FY Mar 2022 | $264.0B |
| Jun 2026 | $105.4B |
| Mar 2026 | $96.3B |
| Dec 2025 | $106.2B |
| Sep 2025 | $103.2B |
| Jun 2025 | $97.8B |
| Mar 2025 | $90.8B |
| Dec 2024 | $95.3B |
| Sep 2024 | $93.7B |
At each fiscal year end
Single quarter
Net margin, TTM
+1.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM MCK
| FY Mar 2026 | +1.2% |
| FY Mar 2025 | +0.9% |
| FY Mar 2024 | +1.0% |
| FY Mar 2023 | +1.3% |
| FY Mar 2022 | +0.4% |
| Jun 2026 | +0.6% |
| Mar 2026 | +1.7% |
| Dec 2025 | +1.1% |
| Sep 2025 | +1.1% |
| Jun 2025 | +0.8% |
| Mar 2025 | +1.4% |
| Dec 2024 | +0.9% |
| Sep 2024 | +0.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$6.4B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MCK
| FY Mar 2026 | $5.7B |
| FY Mar 2025 | $5.5B |
| FY Mar 2024 | $3.9B |
| FY Mar 2023 | $4.8B |
| FY Mar 2022 | $4.0B |
| Jun 2026 | -$332.0M |
| Mar 2026 | $3.3B |
| Dec 2025 | $1.1B |
| Sep 2025 | $2.3B |
| Jun 2025 | -$1.0B |
| Mar 2025 | $7.6B |
| Dec 2024 | -$2.5B |
| Sep 2024 | $2.0B |
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity MCK
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.56x
TTM operating cash flow over long-term 2026-06-30 plus current 2024-12-31 (18 months older than the period end)
Cash flow to debt MCK
| FY Mar 2026 | 0.69x |
| FY Mar 2025 | 0.75x |
| FY Mar 2024 | 0.77x |
| FY Mar 2023 | 0.92x |
| FY Mar 2022 | 0.75x |
| Jun 2026 | 0.56x |
| Mar 2026 | 0.69x |
| Dec 2025 | 1.17x |
| Sep 2025 | 0.67x |
| Jun 2025 | 0.64x |
| Mar 2025 | 0.75x |
| Dec 2024 | 0.31x |
| Sep 2024 | 0.89x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity MCK
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+5.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MCK
| FY Mar 2026 | +6.0% |
| FY Mar 2025 | +4.6% |
| FY Mar 2024 | +4.6% |
| FY Mar 2023 | +5.7% |
| FY Mar 2022 | +1.7% |
| Jun 2026 | +5.4% |
| Mar 2026 | +6.0% |
| Dec 2025 | +5.6% |
| Sep 2025 | +5.2% |
| Jun 2025 | +4.1% |
| Mar 2025 | +4.6% |
| Dec 2024 | +4.1% |
| Sep 2024 | +3.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+101.3%
operating income after a 17.9% effective tax rate, over long-term 2026-06-30 plus current 2024-12-31 (18 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital MCK
| FY Mar 2026 | +256.0% |
| FY Mar 2025 | +384.0% |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | +101.3% |
| Mar 2026 | +256.0% |
| Dec 2025 | +96.9% |
| Sep 2025 | +94.2% |
| Jun 2025 | +57.4% |
| Mar 2025 | +384.0% |
| Dec 2024 | +77.9% |
| Sep 2024 | +342.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+37.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed MCK
| FY Mar 2026 | +43.1% |
| FY Mar 2025 | +30.9% |
| FY Mar 2024 | +26.5% |
| FY Mar 2023 | +30.0% |
| FY Mar 2022 | +11.4% |
| Jun 2026 | +37.2% |
| Mar 2026 | +43.1% |
| Dec 2025 | +39.6% |
| Sep 2025 | +35.3% |
| Jun 2025 | +27.5% |
| Mar 2025 | +30.9% |
| Dec 2024 | +29.6% |
| Sep 2024 | +24.2% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
26.82x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MCK
| FY Mar 2026 | 22.53x |
| FY Mar 2025 | 26.15x |
| FY Mar 2024 | 24.01x |
| FY Mar 2023 | 14.20x |
| FY Mar 2022 | 42.64x |
| Jun 2026 | 20.25x |
| Mar 2026 | 22.53x |
| Dec 2025 | 23.65x |
| Sep 2025 | 24.11x |
| Jun 2025 | 29.32x |
| Mar 2025 | 26.15x |
| Dec 2024 | 26.12x |
| Sep 2024 | 25.63x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$123.7B
market value at close 2026-10-23 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2024-12-31 (18 months older than the period end), minus cash 2026-06-30
Enterprise value MCK
| FY Mar 2026 | $111.0B |
| FY Mar 2025 | $86.7B |
| FY Mar 2024 | $71.6B |
| FY Mar 2023 | $49.7B |
| FY Mar 2022 | $48.2B |
| Jun 2026 | $97.8B |
| Mar 2026 | $111.0B |
| Dec 2025 | $107.3B |
| Sep 2025 | $102.3B |
| Jun 2025 | $99.5B |
| Mar 2025 | $86.7B |
| Dec 2024 | $79.2B |
| Sep 2024 | $66.0B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.5%
TTM free cash flow over market value at close 2026-10-23
FCF yield MCK
| FY Mar 2026 | +5.4% |
| FY Mar 2025 | +6.6% |
| FY Mar 2024 | +5.5% |
| FY Mar 2023 | +9.8% |
| FY Mar 2022 | +8.8% |
| Jun 2026 | +7.1% |
| Mar 2026 | +5.4% |
| Dec 2025 | +9.9% |
| Sep 2025 | +6.6% |
| Jun 2025 | +6.5% |
| Mar 2025 | +6.6% |
| Dec 2024 | +2.7% |
| Sep 2024 | +7.3% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.54x
P/E over trailing EPS growth of 49%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing MCK
| FY Mar 2026 | 0.46x |
| FY Mar 2025 | 1.73x |
| FY Mar 2024 | n/a |
| FY Mar 2023 | 0.06x |
| FY Mar 2022 | n/a |
| Jun 2026 | 0.41x |
| Mar 2026 | 0.46x |
| Dec 2025 | 0.40x |
| Sep 2025 | 0.36x |
| Jun 2025 | 2.47x |
| Mar 2025 | 1.73x |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-03 | 2025-03 | 2024-03 | 2023-03 | |
|---|---|---|---|---|
| Revenue | $403.4B | $359.1B | $309.0B | $276.7B |
| Gross profit | $14.6B | $13.3B | $12.8B | $12.4B |
| Operating income | $6.2B | $4.4B | $3.9B | $4.4B |
| Net income | $4.8B | $3.3B | $3.0B | $3.6B |
| EPS (diluted) | 38.38 | 25.72 | 22.39 | 25.03 |
| Operating cash flow | $6.2B | $6.1B | $4.3B | $5.2B |
| Cash | $4.0B | $5.7B | $4.6B | $4.7B |
| Long-term debt | $6.5B | $5.7B | $5.6B | $5.6B |
| Buybacks | $4.8B | $3.1B | $3.0B | $3.6B |
| Dividends paid | $381.0M | $345.0M | $314.0M | $292.0M |
SEC XBRL, fiscal years, as known on 2026-10-27
MCK Stock Sonar score 6/7 axes
Find similar shapesCompareMCK ranks highest on profitability (88th percentile) and growth (79th), and lowest on insider conviction (5th), among Wholesale & Retail peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MCK filings, in plain words
Are Mckesson insiders buying or selling MCK?
In the 180 days to 2026-10-27, Mckesson insiders were net sellers, a net $24.8M across purchases and sales reported on Form 4, by 7 sellers.
Have members of Congress traded MCK?
Yes. In the year to 2026-10-27, 3 House members disclosed buying MCK and 3 House members disclosed selling it; the latest on record is a purchase by Rick Larsen dated 2026-07-08.
Are there planned insider sales of MCK?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $7.7M of stock; the latest, by Fraga Francisco, was filed 2026-10-15.
Read the full summary
In the 180 days to 2026-10-27, Mckesson insiders were net sellers of MCK, a net $24.8M across purchases and sales reported on Form 4 by 7 sellers. 17% of the 12 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-27, 3 members of Congress disclosed buying MCK and 3 members disclosed selling it; the latest on record is a purchase by Rick Larsen dated 2026-07-08. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $7.7M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
